Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Anuradha R Thummala is associated with these group practices

Procedure Pricing

HCPCS Code Definitions

Q9967

Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml

J3475

Injection, magnesium sulfate, per 500 mg

96366

Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

J2469

Injection, palonosetron hcl, 25 mcg

96365

Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour

J2060

Injection, lorazepam, 2 mg

96361

Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)

J3420

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

99232

Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.

A9552

Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

J3430

Injection, phytonadione (vitamin k), per 1 mg

96360

Intravenous infusion, hydration; initial, 31 minutes to 1 hour

99233

Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.

78815

Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh

99204

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.

74178

Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions

96372

Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular

71260

Computed tomography, thorax; with contrast material(s)

J3487

Injection, zoledronic acid (zometa), 1 mg

J3480

Injection, potassium chloride, per 2 meq

38221

Bone marrow; biopsy, needle or trocar

J3488

Injection, zoledronic acid (reclast), 1 mg

J9310

Injection, rituximab, 100 mg

J9265

Injection, paclitaxel, 30 mg

J2916

Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg

J1200

Injection, diphenhydramine hcl, up to 50 mg

96367

Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)

J1441

Injection, filgrastim (g-csf), 480 mcg

96415

Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

J9045

Injection, carboplatin, 50 mg

96374

Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug

G0364

Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service

96375

Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)

J7030

Infusion, normal saline solution , 1000 cc

J1440

Injection, filgrastim (g-csf), 300 mcg

J7040

Infusion, normal saline solution, sterile (500 ml=1 unit)

J1100

Injection, dexamethasone sodium phosphate, 1mg

J9035

Injection, bevacizumab, 10 mg

J9190

Injection, fluorouracil, 500 mg

J9171

Injection, docetaxel, 1 mg

J9201

Injection, gemcitabine hydrochloride, 200 mg

99222

Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.

96413

Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

96411

Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separately in addition to code for primary procedure)

96409

Chemotherapy administration; intravenous, push technique, single or initial substance/drug

96402

Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic

99203

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.

J0897

Injection, denosumab, 1 mg

J0881

Injection, darbepoetin alfa, 1 microgram (non-esrd use)

J0610

Injection, calcium gluconate, per 10 ml

96417

Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)

96523

Irrigation of implanted venous access device for drug delivery systems

J0640

Injection, leucovorin calcium, per 50 mg

96521

Refilling and maintenance of portable pump

99205

Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.

J2505

Injection, pegfilgrastim, 6 mg

J1626

Injection, granisetron hydrochloride, 100 mcg

99213

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.

J2780

Injection, ranitidine hydrochloride, 25 mg

99215

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.

99214

Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.

Medical Malpractice Cases

Medical Board Sanctions

Referrals

Publications

Map & Directions

Nearby Doctors

I understand that I may be contacted by a third party that may or may not be a physician and that by providing your information to us, you agree to be contacted by phone and or email for the purposes of obtaining information on requesting more information in regards to an appointment with a physician.